News | October 03, 2024
CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Time to combine innovation, access and technology to deliver positive patient outcomes
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
To focus on providing safer burn treatments for women and armed forces
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)